Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Atorvastatin for bronchial hyper-responsiveness
ACTRN12609000704291Phase 2Recruiting
- Sponsor
- Shahid Beheshti University of Medical Sciences
- Start
- Oct 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of atorvastatin in airway hyperresponsiveness (AHR) (2 arms), sponsored by Shahid Beheshti University of Medical Sciences. Primary endpoint: Decrease in bronchial hyper-responsiveness on methacholine challenge test. Started Oct 2008; status: recruiting.
02
Drugs
atorvastatin
03
Conditions
airway hyperresponsiveness (AHR)
Beyond the preview
Go deeper on ACTRN12609000704291.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12609000704291.